跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,445 条关于
“Myasthenia gravis”
全部
2,445
临床试验
1,403
药物
67
机构
21
资讯
954
去年
Efgartigimod Shows Sustained Improvement in Myasthenia Gravis Patients
去年
Eculizumab Shows Promise in Treating Thymoma-Associated Myasthenia Gravis
去年
Rozanolixizumab Self-Administration Study Shows Promise for Myasthenia Gravis Patients
去年
Amgen's Rocatinlimab Shows Promise in Eczema Trial, Myasthenia Gravis Treatment Also Succeeds
去年
RemeGen's Telitacicept Receives Approval in China for Generalized Myasthenia Gravis Treatment
去年
Rozanolixizumab Shows Efficacy in Older Adults with Generalized Myasthenia Gravis
2年前
European Study Reveals Harmful Impact of Delayed Myasthenia Gravis Diagnosis
2年前
Nipocalimab Shows Sustained Disease Control in Adolescents with Generalized Myasthenia Gravis
去年
Study Reveals Link Between AChR Antibody Levels and Myasthenia Gravis Treatment Response
去年
FDA Approves Rystiggo (rozanolixizumab-noli) for Generalized Myasthenia Gravis
第 1 页,共 96 页
上一页
下一页